ABBOTT LABORATORIES(ABT)- Financials

ABT
ABBOTT LABORATORIES
133.58

-0.36 (-0.27%) 06/06 close, EST

Signals
Analysis
Financials
Charts
Dividends

Annualized
Annual
Quarterly

Income Statement million USD

	03/31/25	12/31/24	09/30/24	06/30/24	03/31/24
Revenue	42,344	41,950	41,217	40,725	40,326
Cost of Revenue	18,711	18,706	18,320	18,227	18,107
Gross Profit	23,633	23,244	22,897	22,498	22,219
SG&A	11,799	11,697	11,514	11,342	11,146
R&D	2,876	2,844	2,795	2,754	2,771
Operating Income	7,132	6,825	6,694	6,482	6,355
EBITDA	11,073	10,790	10,584	10,362	10,405
Other Income Exp	772	747	666	633	808
intexp	549	559	582	606	625
Tax Expense	-6,147	-6,389	1,011	952	908
Discontinued Ops	0	0	0	0	0
Net Income	13,502	13,402	5,767	5,557	5,630

Balance Sheet million USD

	03/31/25	12/31/24	09/30/24	06/30/24	03/31/24
Cash, Cash Equivalents	6,532	7,616	7,558	6,987	6,284
Short-Term Investments	312	351	230	232	367
Receivables	7,327	6,925	7,051	6,854	6,605
Inventory	6,639	6,194	6,813	6,814	6,827
Long-Term Investments	907	886	912	877	818
Net PPE	10,932	10,658	10,621	10,233	10,107
Intangible Assets	29,620	29,755	31,010	31,135	31,679
Deferred Tax Assets	16,836	16,459	8,011	7,653	7,487
Others Assets	2,343	2,570	2,150	2,232	2,293
Total Assets	81,448	81,414	74,356	73,017	72,467
Payables	4,214	4,195	4,034	4,125	4,178
Total Debt	13,242	14,125	14,979	14,754	14,586
Deferred Revenue	0	0	0	0	0
Deferred Tax Liabilities	485	594	713	601	562
Other Liabilities	14,443	14,599	14,602	13,977	14,098
Total Liabilities	32,384	33,513	34,328	33,457	33,424
Paid-in Capital + APIC	8,766	8,546	8,776	9,341	9,198
Retained Earnings	47,715	47,261	39,056	38,354	38,011
AOCI	-7,417	-7,906	-7,804	-8,135	-8,166
Total Equity	49,064	47,901	40,028	39,560	39,043
Shares Outstanding	174,722	174,800	174,759	175,115	174,965

Cash Flow Statement million USD

	03/31/25	12/31/24	09/30/24	06/30/24	03/31/24
Operating Cash Flow	8,950	8,558	8,728	7,900	7,143
Investing Cash Flow	-2,383	-2,338	-2,296	-2,336	-3,096
Financing Cash Flow	-6,283	-5,404	-5,595	-6,359	-6,857
Effect of Exchange Rate	-36	-96	12	-53	-67
Net Increase/Decrease in Cash	248	720	849	-848	-2,877
Capital Expenditures	-2,293	-2,207	-2,242	-2,246	-2,220
Free Cash Flow	6,657	6,351	6,486	5,654	4,923

Important Notice
All content provided by DATAHERO is solely for informational purposes and is not posted with the intention to sell or recommend specific stocks. The content of DATAHERO is not a research report and should not be used as the sole basis for investment decisions. All investments carry risk, and past performance of financial products does not guarantee future results or returns. When investing in financial products, one should always be aware of the possibility of financial loss and investors should carefully consider their investment objectives and risks before investing.

Income Statement million USD

Balance Sheet million USD

Cash Flow Statement million USD

US STOCK SIGNAL Premium

AI Signals

Term Explanation

Watchlist stocks.

Watchlist stocks.

Recommendation Service